BRIEF published on 04/15/2025 at 23:35, 1 year 4 months ago AI/ML Innovations Completes Oversubscribed Private Placement Private Placement Investor Confidence AI/ML Innovations Healthcare AI Unit Offering
BRIEF published on 04/15/2025 at 23:35, 1 year 4 months ago AI/ML Innovations finalise un placement privé sursouscrit Placement Privé Confiance Des Investisseurs IA Dans Le Domaine De La Santé Innovations En IA/ML Offre D'unités
BRIEF published on 04/15/2025 at 23:05, 1 year 4 months ago Cerrado Gold Reports Q1 2025 Production Results at Minera Don Nicolas Mine Gold Production Underground Mining Heap Leach Operations Mont Sorcier Project Crushing Circuit Expansion
BRIEF published on 04/15/2025 at 23:05, 1 year 4 months ago Cerrado Gold publie les résultats de production du premier trimestre 2025 à la mine Minera Don Nicolas Production D'or Exploitation Minière Souterraine Opérations De Lixiviation En Tas Projet Mont Sorcier Extension Du Circuit De Concassage
BRIEF published on 04/15/2025 at 22:05, 1 year 4 months ago Inventiva Files 2024 Financial Documents with Regulatory Agencies Biopharmaceutical Regulatory Filing Inventiva MASH 2024 Financials
BRIEF published on 04/15/2025 at 22:05, 1 year 4 months ago Inventiva dépose ses documents financiers 2024 auprès des agences réglementaires Biopharmaceutique Dépôt Réglementaire Résultats Financiers 2024 Inventiva ÉCRASER
BRIEF published on 04/15/2025 at 21:56, 1 year 4 months ago Adtran Networks SE Revises 2024 Financial Expectations Adtran Networks Financial Results 2024 Inventory Adjustment Expected Loss IFRS Pro Forma EBIT
BRIEF published on 04/15/2025 at 21:56, 1 year 4 months ago Adtran Networks SE révise ses prévisions financières pour 2024 Résultats Financiers 2024 Ajustement Des Stocks Réseaux Adtran Perte Attendue EBIT Pro Forma IFRS
BRIEF published on 04/15/2025 at 19:53, 1 year 4 months ago Medincell accroît son contrat de liquidité pour soutenir l'échange de titres Contrat De Liquidité Rothschild Martin Maurel Actions Réglementation UE Medincell
BRIEF published on 04/15/2025 at 19:53, 1 year 4 months ago Medincell increases its liquidity contract to support securities trading Liquidity Contract Rothschild Martin Maurel Actions EU Regulations Medincell
Published on 09/11/2026 at 17:00, 3 hours 41 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 3 hours 41 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 5 hours 16 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 5 hours 41 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 6 hours 11 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 19:44, 57 minutes ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 18:15, 2 hours 26 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 2 hours 41 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 13 hours 41 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 13 hours 41 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 13 hours 41 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 13 hours 41 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
